Other Species / Isoforms
  ADCK5 (mouse)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K173-ub
TLRVLEDkALTRGFR
0 1
ADCK5 (human) TLRVLEDRALKRGFQ R173
ADCK5 (mouse) TLRVLEDkALTRGFR K173-ub
ADCK5 (rat) TLRVLEDKALTRGFR K173
K330-ub
VNDMEGIkSQGLAVQ
0 1
ADCK5 (human) VNDVEAIRSQGLAVH R330
ADCK5 (mouse) VNDMEGIkSQGLAVQ K330-ub
ADCK5 (rat) VNDMEGIKSQGLAVQ K330
H353
TFAEQIFHTGFIHSD
0 1
ADCK5 (human) AFAEQIFytGFIHsD Y353-p
ADCK5 (mouse) TFAEQIFHTGFIHSD H353
ADCK5 (rat) TFAEQIFHTGFIHSD H353
T354
FAEQIFHTGFIHSDP
0 1
ADCK5 (human) FAEQIFytGFIHsDP T354-p
ADCK5 (mouse) FAEQIFHTGFIHSDP T354
ADCK5 (rat) FAEQIFHTGFIHSDP T354
S359
FHTGFIHSDPHPGNV
0 1
ADCK5 (human) FytGFIHsDPHPGNV S359-p
ADCK5 (mouse) FHTGFIHSDPHPGNV S359
ADCK5 (rat) FHTGFIHSDPHPGNV S359
Y386-p
VLLDHGLyQFLDEKD
Upstream
0 1
Treatment
  • long-term_potentiation
ADCK5 (human) VLLDHGLYQFLEEKD Y386
ADCK5 (mouse) VLLDHGLyQFLDEKD Y386-p
ADCK5 (rat) VLLDHGLYQFLDEKD Y386
S444-p
RLGQLWGsHLISREE
Upstream
0 1
Treatment
  • insulin
ADCK5 (human) RLGQLWGSHLLSREE S444
ADCK5 (mouse) RLGQLWGsHLISREE S444-p
ADCK5 (rat) RLGQLWGSHLISREE S444
Y520
SRLVGAAYQGIYGSS
0 1
ADCK5 (human) SRLAGATyRGVyGTS Y520-p
ADCK5 (mouse) SRLVGAAYQGIYGSS Y520
ADCK5 (rat) SRLVGAAYQGIYSSR Y520
Y524
GAAYQGIYGSSLLRH
0 1
ADCK5 (human) GATyRGVyGTSLLRH Y524-p
ADCK5 (mouse) GAAYQGIYGSSLLRH Y524
ADCK5 (rat) GAAYQGIYSSRLLRH Y524